• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估麦吉尔大学附属医院类风湿关节炎的治疗过程。

Assessing process of care in rheumatoid arthritis at McGill University hospitals.

机构信息

Division of Rheumatology, McGill University, Montréal, Quebec, Canada.

出版信息

J Clin Rheumatol. 2013 Jun;19(4):175-9. doi: 10.1097/RHU.0b013e3182937094.

DOI:10.1097/RHU.0b013e3182937094
PMID:23669798
Abstract

OBJECTIVE

In rheumatoid arthritis (RA), quality indicators (QIs) are tools used to measure process of care. This study aimed to assess performance of selected QIs from the 2004 Arthritis Foundation's QI Set at 2 major sites of a university network of teaching hospitals.

METHODS

The charts and electronic hospital records of 76 RA patients were audited to determine adherence to QIs. Logistic multivariate regression analyses were performed to investigate potential determinants of nonadherence and propose measures to facilitate better QI compliance, as a potential strategy towards RA care improvement.

RESULTS

We identified consistent observance of QIs mandating prescription of disease-modifying antirheumatic drug therapy for all patients, drug adjustment with disease activity, prednisone tapering, and bisphosphonate therapy if indicated for patients on glucocorticoids. However, there was either lack of documentation or true inconsistent adherence to QIs dealing with radiograph performance, functional capacity assessment, and screening for hepatitis and tuberculosis before commencement of methotrexate and biologic agents, respectively. For the specific QIs analyzed, we did not find any definite independent associations with the studied variables.

CONCLUSIONS

Our findings indicate that while there is frequent evidence for adherence to certain RA quality care standards at our centers, there is less compliance to others. Strategies to optimize the performance or documentation of those found most lacking, namely, functional capacity and screening for specific drug contraindications, could improve patient care. Radiographic disease monitoring, while lacking, may represent a move toward other more sensitive methods of RA progression detection, such as joint ultrasound. The inclusion of patient- and physician-derived information could help elucidate the reasons underlying nonadherence.

摘要

目的

在类风湿关节炎(RA)中,质量指标(QI)是用于衡量治疗过程的工具。本研究旨在评估大学网络教学医院的 2 个主要站点使用 2004 年关节炎基金会 QI 集的选定 QI 的表现。

方法

对 76 例 RA 患者的图表和电子病历进行审核,以确定对 QI 的遵守情况。进行逻辑多元回归分析,以调查非依从性的潜在决定因素,并提出促进更好的 QI 依从性的措施,作为改善 RA 护理的潜在策略。

结果

我们发现,对于所有患者,都一致遵守了规定使用疾病修饰抗风湿药物治疗的 QI,根据疾病活动度调整药物、泼尼松减量,以及对于正在使用糖皮质激素的患者使用双膦酸盐治疗。然而,在开始使用甲氨蝶呤和生物制剂之前,分别在影像学表现、功能能力评估以及筛查乙型肝炎和结核病方面,存在缺乏文件记录或真正不遵守 QI 的情况。对于分析的特定 QI,我们没有发现任何与研究变量有明确独立关联的情况。

结论

我们的研究结果表明,虽然我们中心经常有证据表明对某些 RA 质量护理标准的遵守,但对其他标准的遵守程度较低。优化那些发现最缺乏的 QI 的性能或记录的策略,即功能能力和特定药物禁忌的筛查,可能会改善患者的护理。影像学疾病监测虽然缺乏,但可能代表着向其他更敏感的 RA 进展检测方法的转变,如关节超声。包括患者和医生提供的信息可以帮助阐明不依从的原因。

相似文献

1
Assessing process of care in rheumatoid arthritis at McGill University hospitals.评估麦吉尔大学附属医院类风湿关节炎的治疗过程。
J Clin Rheumatol. 2013 Jun;19(4):175-9. doi: 10.1097/RHU.0b013e3182937094.
2
Assessment of American College of Rheumatology-Endorsed Quality Indicators in Rheumatoid Arthritis Patients: A Quality Improvement Initiative.类风湿关节炎患者中美国风湿病学会认可的质量指标评估:一项质量改进计划。
J Clin Rheumatol. 2016 Mar;22(2):63-7. doi: 10.1097/RHU.0000000000000323.
3
American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record.美国风湿病学会类风湿关节炎质量指标:使用电子健康记录进行基准测试、变异性分析及改善医疗质量的机会
Arthritis Rheum. 2008 Dec 15;59(12):1705-12. doi: 10.1002/art.24054.
4
Care quality for rheumatoid arthritis patients in Quebec.魁北克类风湿关节炎患者的护理质量。
Int J Rheum Dis. 2019 Jul;22(7):1233-1238. doi: 10.1111/1756-185X.13580. Epub 2019 Apr 16.
5
Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus.评价类风湿关节炎患者医疗质量的指标:韩国专家共识。
J Korean Med Sci. 2021 May 3;36(17):e109. doi: 10.3346/jkms.2021.36.e109.
6
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.小剂量泼尼松加入甲氨蝶呤为基础的紧密控制策略治疗早期类风湿关节炎:一项随机试验。
Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004.
7
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.采用对症治疗、改善病情抗风湿药或生物制剂治疗极早期类风湿关节炎:一项成本效益分析。
Ann Intern Med. 2009 Nov 3;151(9):612-21. doi: 10.7326/0003-4819-151-9-200911030-00006.
8
Measuring quality of care for rheumatic diseases using an electronic medical record.使用电子病历测量风湿病的医疗质量。
Ann Rheum Dis. 2009 May;68(5):680-4. doi: 10.1136/ard.2008.089318. Epub 2008 May 29.
9
Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators.类风湿关节炎心血管风险应对中的差距:使用心血管质量指标评估绩效
J Rheumatol. 2016 Nov;43(11):1965-1973. doi: 10.3899/jrheum.160241. Epub 2016 Aug 1.
10
Quality indicators in rheumatoid arthritis: results from the METEOR database.类风湿关节炎的质量指标:来自 METEOR 数据库的结果。
Rheumatology (Oxford). 2015 Sep;54(9):1630-9. doi: 10.1093/rheumatology/kev108. Epub 2015 Apr 14.

引用本文的文献

1
Latent Tuberculosis Screening Among New Users of a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: Gaps in Screening Overall and Among Janus Kinase Inhibitors.生物制剂或靶向合成疾病修正抗风湿药物新使用者的潜伏性结核病筛查:总体筛查和 Janus 激酶抑制剂筛查中的差距。
Arthritis Care Res (Hoboken). 2024 Jul;76(7):1037-1044. doi: 10.1002/acr.25318. Epub 2024 Mar 18.
2
RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs.RISE 注册研究揭示了生物制剂和靶向合成 DMARDs 新使用者在药物安全方面的潜在差距。
Semin Arthritis Rheum. 2020 Dec;50(6):1542-1548. doi: 10.1016/j.semarthrit.2020.03.003. Epub 2020 Mar 19.
3
Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications.
免疫抑制专科药物门诊患者安全方面的差距。
Jt Comm J Qual Patient Saf. 2019 May;45(5):348-357. doi: 10.1016/j.jcjq.2018.12.003. Epub 2019 Jan 25.
4
Timing and Impact of Decisions to Adjust Disease-Modifying Antirheumatic Drug Therapy for Rheumatoid Arthritis Patients With Active Disease.类风湿关节炎患者疾病活动时调整抗风湿药物治疗的决策时机和影响。
Arthritis Care Res (Hoboken). 2018 Jun;70(6):834-841. doi: 10.1002/acr.23418. Epub 2018 Apr 16.
5
A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.系统性综述影响风湿性疾病患者药物依从性的障碍因素。
Rheumatol Int. 2017 Oct;37(10):1619-1628. doi: 10.1007/s00296-017-3763-9. Epub 2017 Jul 5.